Diagnostic value of signal peptide-Complement C1r/C1s, Uegf, and Bmp1-epidermal growth factor domain-containing protein 1 on serum and tissue samples in non-small cell lung cancer


Gurz S., ÇELİK B., MENTEŞE A., Altay D. U.

TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, vol.26, no.2, pp.246-253, 2018 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 2
  • Publication Date: 2018
  • Doi Number: 10.5606/tgkdc.dergisi.2018.14600
  • Journal Name: TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
  • Journal Indexes: Science Citation Index Expanded, Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.246-253
  • Keywords: Diagnosis, lung cancer, signal peptide-Cub-epidermal growth factor domain-containing protein 1, GASTRIC-CANCER, SCUBE1

Abstract

Background: This study aims to investigate whether there is any relationship between the type, stage and the extensiveness of lung cancer and levels of signal peptide-Complement Clr/Cls, Uegf, and Bmpl-epidermal growth factor domain-containing protein 1 in serum and lung tissues of non-small cell lung cancer patients and also whether there is any difference in signal peptide-Complement Clr/Cls, Uegf, and Bmpl-epidermal growth factor domain-containing protein 1 levels of patients with malignant or benign diseases.